DI MARIO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 11265
AS - Asia 7030
EU - Europa 5934
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 7
SA - Sud America 4
Totale 24299
Nazione #
US - Stati Uniti d'America 11075
CN - Cina 5539
SE - Svezia 2266
TR - Turchia 1409
UA - Ucraina 1199
FI - Finlandia 905
DE - Germania 701
IT - Italia 443
CA - Canada 188
GB - Regno Unito 161
BE - Belgio 62
EU - Europa 59
AT - Austria 43
RO - Romania 38
FR - Francia 37
IR - Iran 35
NL - Olanda 32
IN - India 19
CZ - Repubblica Ceca 18
JP - Giappone 12
IE - Irlanda 8
SK - Slovacchia (Repubblica Slovacca) 7
CI - Costa d'Avorio 6
HK - Hong Kong 5
RU - Federazione Russa 5
IL - Israele 4
CL - Cile 3
ES - Italia 2
GR - Grecia 2
PL - Polonia 2
VN - Vietnam 2
BG - Bulgaria 1
EC - Ecuador 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
SM - San Marino 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 24299
Città #
Chandler 3216
Dearborn 1619
Nanjing 1309
Izmir 1233
Jacksonville 1222
Beijing 1190
Princeton 831
Wilmington 464
San Mateo 446
Ann Arbor 399
Shenyang 372
Nanchang 353
Hebei 297
Kunming 239
Helsinki 237
Jinan 216
Changsha 203
Jiaxing 198
Tianjin 198
Hefei 182
Kocaeli 174
Toronto 167
Boardman 140
Parma 134
Norwalk 131
Hangzhou 101
Fremont 91
Guangzhou 91
Zhengzhou 79
Des Moines 72
Bremen 70
Ningbo 64
Brussels 57
Woodbridge 48
Houston 44
Vienna 41
Grafing 38
Taizhou 35
Haikou 32
Lanzhou 32
Cambridge 28
Borås 27
Fuzhou 25
Shaoxing 25
Chengdu 24
Rockville 24
Taiyuan 24
Wuhan 23
Leawood 22
Seattle 22
Timisoara 20
Xian 20
Chongqing 19
Redmond 17
Andover 15
Changchun 15
Milan 15
Augusta 14
Rio Saliceto 13
Redwood City 11
Wenzhou 11
Ashburn 10
Baotou 10
Zanjan 10
Auburn Hills 9
Focsani 9
Quzhou 8
Bratislava 7
Brno 7
Bucharest 7
Chieti 7
Huzhou 7
Old Bridge 7
Düsseldorf 6
Falls Church 6
Fontanellato 6
Geislingen an der Steige 6
Huizen 6
Kagoya 5
Modena 5
Orange 5
Yinchuan 5
Cesano 4
Dublin 4
Fairfield 4
Fryazino 4
Monmouth Junction 4
Sabz 4
Sacramento 4
Shanghai 4
Tampere 4
Ardabil 3
Calenzano 3
Espoo 3
Jinhua 3
Legnaro 3
Little Rock 3
Los Angeles 3
Mumbai 3
Nürnberg 3
Totale 16690
Nome #
Recovery of gastric function in patients affected by chronic atrophic gastritis using L-cysteine (Acetium®): one year survey in comparison with a control group 77
Approach to gastroenterological diseases in primary care 72
Autonomic balance in inflammatory bowel diseases, irritable bowel syndrome and gastroesophageal reflux disease 65
Are 6 days of a triple clarithromycin based therapy sufficient to obtain the cure of H pylori infection? 61
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey 59
Thyroid and celiac disease in pediatric age: a literature review 59
How and when investigating and treating Helicobacter pylori infection in children 59
Long-Term Clinical Outcome of Elderly Patients With Reflux Esophagitis: A Six-Month to Three-Year Follow-up Study 58
Eosinophilic esophagitis in pediatric age, state of the art and review of the literature 58
Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients 56
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? 56
La Biopsie biochimica gastrica 55
Growth changes after gluteen free diet in pediatric celiac patients: a literature-review 55
5 OP Keratin 8 gene mutation in patients with chronic pancreatitis 55
Bovine lactoferrin as a rescure treatment for Helicobacter pylori infection: results of a multicenter study 54
Prevalence of gastrointestinal diseases in elderly population: epidemiological survey in north-east of Italy 54
Treatment of Helicobacter pylori infection. 53
Usefullness of gastropanel in different topography of H. pylori related chronic gastritis 52
MONOCYTE CHEMOTACTIC PROTEIN -1 POLYMORPHISM IS ASSOCIATED WITH ACUTE RECURRENT PANCREATITIS 52
Association of HLA-DRB1 *0401 Allele with chronic pancreatitis 52
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 52
Gastropanel as screening of gastric atrophy in primary care 51
Associations of Spink-1 (N34S) and PRSS-1 (N29I and R122H) gene mutations and chronic pancreatitis in Italy 51
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study 51
Keratin 8 mutations in patients with chronic pancreatitis 51
Efficacy of a therapeutic strategy for eradication ofHelicobacter pyloriinfection 51
Recovery of gastric function after H. pylori eradication in subjects with body atrophic gastritis: a prospective four years study 51
MODIFICAZIONI DELLA MUCOSA GASTRICA IN CORSO DI TRATTAMENTO DELLA MALATTIA ULCEROSA 51
Effects of gastroesophageal reflux disease in laryngeal carcinoma 50
Low-doses versus standard-doses of clarithromicin in combination with amoxycillin and rabeprazole for the eradication of H. pylori infection in elderly subjects 50
Association of keratin 8 gene mutation with chronic pancreatitis 50
Hypercalcemia due to ectopic secretion of parathyriod related protein from pancreatic carcinoma: a case report 50
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety 50
CONNECTIONS BETWEEN GENETICS ANCùD CLINICAL DATA:ROLE OF MCP-1 , CFTR AND SPINK-1 IN THE CLINICAL SETTING OF ACUTE,ACUTE RECURRENT AND CHRONIC PANCREATITIS. 50
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 50
Helicobacter pylori infection in children and adults: a single pathogen but a different pathology 50
Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact? 50
Therapy of NERD: single Vs double rabeprazole dosage 49
Epidemiology and risk factors of pancreatic cancer 49
Lactoferrin: mechanism of action, clinical significance and therapeutic 48
Diagnosis of H. pylori gastritis patterns by means of gastropanel 48
Imaging of a small bowel cavernous hemangioma: report of a case with emphasis on the use of computed tomography and enteroclysis. 48
Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs 47
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome 47
Clinical usefulness of Gastropanel (SPGI, SPGII, GASTRIN-17, HP SPECIFIC IgG) in the assessment of HP infection 47
Lactoferrin in a 1-week triple therapy for eradication of H. pylori 47
Topography of gastric damage in H.pylori infection: evaluation by serum pepsinogens levels 47
Pantoprazole in eradication of peptic ulcer H pylori (Hp) positive patients: a multicentre randomized prospective study by gisu (interdisciplinary ulcer study group) 47
Prognostic factors for the success of helicobacter pylori cure: a prospective study 47
‘Serological Biopsy’ in first degree relatives of patients with gastric cancer, affected by Helicobacter pylori 47
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. 47
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 47
Rabeprazole/Levofloxacin based triple therapy as a salvatage treatment failure of H. pylori eradication with standard regimens 47
The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter study. 47
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 47
Conservative treatment of acute appendicitis 47
Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels 46
Natural course of functional dyspepsia after after helicobacter pylori eradication a 7-year survey 46
Rabeprazole for the treatment of oropharingeal picture of GERD: a six-month prospective study 46
Prevalence of H. pylori CagA+ve in suburban area with high incidence of gastric cancer 46
'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection 46
Comparison of two dosages of clarithromycin in combination with amoxycillin and pantoprazole for the eradication of H. pylori infection in elderly subjects 46
Virulence H. pylori genes cagA and oipA interplay with IL1b and IL1-RN host genes in favoring preneoplastic and neoplastic gastric lesions 46
OLGA staging for gastritis: a tutorial. 46
Role of Helicobacter pylori infection on NSAIDs-related upper gastrointestinal bleeding in the elderly 46
Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia 46
P.1.288: PEPSINOGEN I, II, RATIO, AND G-17 IN PATIENTS WITH ESOPHAGITIS AND PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD 46
Autoimmune diseases in autoimmune atrophic gastritis 46
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 46
Quadro clinico ed endoscopico 45
COX1 plus PPI or COX2 in acute osteoarthritis for prevention of gastroduodenal damage ? A prospective four weeks study 45
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. 45
Acid-related disorders in the elderly 45
Risk of tumor implantation in percutaneous endoscopic gastrostomy in the upper aerodigestive tumors 45
THE SIZE OF PANCREATIC PSEUDOCYST DOES NOT INFLUENCE THE OUTCOME OF INVASIVE TREATMENTS 45
Serum pepsinogen II as a biomarker in management of H. pylori infection 45
Emorragia gastrointestinale 45
Double, 14-day therapy with omeprazole and clarithromycin is not sufficiently effective for the cure of Helicobacter pylori infection. Comparison with two triple 7-day therapies 45
Cancer adenomas founbd during 15 years of screening in the Alto Vicentino area (north-east Italy) 45
Use of BOVINE lactoferrin for Helicobacter pylori eradication 44
Atlante a colori delle malattie dell'apparato digerente. Malattie del colon" 44
La gestione del paziente dispeptico: nuove acquisizioni e antichi problemi. Gastroenterologia Clinica 44
Comparison with omeprazole, lansoprazole and pantoprazole in the treatment of elderly patients with oesophagitis 44
PANCREATIC PSEUDOCYSTS FOLLOWING ACUTE PANCREATITIS: RISK FACTORS INFLUENCING THERAPEUTIC OUTCOMES 44
A symptom-orientated PPI strategy in the treatment of the ENT manifestations of GERD. 44
Chronic nicotine intake causes vascular dysregulation in the rat gastric mucosa 44
The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs 44
Retreatment after failure of Helicobacter pylori eradication: quadruple vs ranitidine bismuth citrate 2 weeks therapy 44
A prospective therapeutical one-year study with pantoprazole for patients with oropharingeal picture of GERD 44
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population 44
P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area 44
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 44
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 44
Efficacy of 5-ASA in the treatment of colonic diverticular disease 44
Clinical usefulness of serum pepsinogen II in the assessment of H. pylori infection 43
Symptoms in GERD, NERD and gastroduodenal reflux 43
Efficacy of mesalazine in the treatment of symptomatic diverticular disease 43
Is the buried bumper sindrome a buried problem? Personal experience about a different therapeutic approach and prevention possibilities 43
Helicobacter pylori “resistente”. La gestione del paziente con infezione da Helicobacter pylori resistente alla terapia 43
The long term outcome of gastric non-invasive neoplasia 43
Totale 4887
Categoria #
all - tutte 45921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018876 0000 07 946 352442911
2018/20192960 712126 337433 4647 205361476343
2019/20208024 21441042277145 5621193 817184 411789173287
2020/20212322 4727827218 29549 26011 43123537254
2021/20223602 472352224 20659 213444 1763103421506
2022/20236287 154013379841304 11220 00 0000
Totale 25007